DOSSIER · UPDATED 18 NOV 2025

Aviceda Therapeutics

Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation…

avicedarx.com ↗Claim this profile

Founded: 2018
Headcount: 53
Open roles: 0
Last raised: Series C · $208M

SECTION I · THE BRIEF

Inside Aviceda Therapeutics

Brief #86959Updated 18 NOV 2025CAMBRIDGEMEDICAL ORGANIZATIONSSERIES C

Employbl Dossier

Aviceda Therapeutics

Founded: 2018
Headcount: 53
Open roles: 0
Last raised: Series C · $208M

Section II · Premium ProfileMembers only

01Engineering interview process at Aviceda TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Aviceda Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Mohamed Genead

OPEN ROLES

Hiring at Aviceda Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $276,810,976